About this policy
The comment period for the MolDX: EndoPredict Breast Cancer Gene Expression Test DL37663 Local Coverage Determination (LCD) began on 04/23/20 and ended on 07/07/20. The notice period for L37663 begins on 05/20/21 and will become effective on 07/4/21. The comments below were received from the provider community. Thank you for the comments.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.